CureVac NV
(MEX:CVAC)
MXN
62
0 (0%)
Market Cap: 13.18 Bil
Enterprise Value: 2.05 Bil
PE Ratio: 5.13
PB Ratio: 0.80
GF Score: 62/100 CureVac NV at Jefferies Healthcare Conference Transcript
Jun 09, 2022 / 01:30PM GMT
Release Date Price:
MXN344
Eun Kyung Yang
Jefferies LLC, Research Division - MD & Senior Equity Research Analyst
Happy to conduct a fire sided chat with the CureVac, and presenting from CureVac is Pierre, CFO and Sarah, Head of IR. So thanks for joining me today this morning.
Pierre Kemula
CureVac N.V. - MD, CFO & Member of Management Board
Thank you very much.
Sarah Fakih
CureVac N.V. - VP Corporate Communications & IR
Thank you.
Eun Kyung Yang
Jefferies LLC, Research Division - MD & Senior Equity Research Analyst
Okay. So before we go in -- before we go into specific questions, can you talk -- give us a kind of overview of what CureVac is trying to achieve?
Pierre Kemula
CureVac N.V. - MD, CFO & Member of Management Board
Absolutely. Good morning, everyone. It's a pleasure to be here. So I mean, we are basically an mRNA company, right, trying to, of course, express all the value of mRNA in infectious diseases. We've announced
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot